Drug: LUPRON Injury: Prostatic specific antigen increased Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
106338383 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 0.00 | M | 0 | 20160915 | US |
111819743 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 64.91 YR | M | 0 | 20160915 | US |
111822813 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 81.78 YR | M | 0 | 20160915 | US |
111825193 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 0.00 | M | 0 | 20160915 | US |
115033952 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 69.98 YR | M | 0 | 20160915 | US |
125739042 | LUPRON | Prostatic specific antigen increased | AMGEN | 69.00 YR | M | 0 | 20160808 | US |
127495101 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 82.05 YR | M | 0 | 20160915 | US |
127506831 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 79.53 YR | M | 0 | 20160915 | US |
127507001 | LUPRON | Prostatic specific antigen increased | ASTELLAS | 77.70 YR | M | 0 | 20160915 | US |
Total Records: 9 Number of Pages: 1